Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aldurazyme in MPS I Patients < 5 Years
NCT00146757Phase 2Completed
- Sponsor
- Sanofi
- Start
- Oct 2002
- Primary completion
- May 2005
- Modality
- Replacement Enzymes
- Countries
- 4
01
Overview
A Phase 2 trial of laronidase in mucopolysaccharidosis type I, sponsored by Sanofi. Started Oct 2002; status: completed.
02
Drugs
laronidase
03
Conditions
mucopolysaccharidosis type I
Beyond the preview
Go deeper on NCT00146757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00146757.